Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Last time updated on 16/05/2021